Gain in Quality-adjusted Life-years in Patients with Rheumatoid Arthritis During 1 Year of Biological Therapy: A Prospective Study in Clinical Practice

Medicine & Life Sciences

• Biological Therapy 100%
• C-Reactive Protein 21%
• Comorbidity 9%
• Health 11%
• Health Care Outcome Assessment 7%
• Immunoglobulin M 10%
• Joints 42%
• Prospective Studies 53%
• Quality of Life 46%
• Quality-Adjusted Life Years 93%
• Rheumatic Diseases 51%
• Rheumatoid Arthritis 70%
• Rheumatoid Factor 14%
• Rheumatology 13%
• Therapeutics 1%